小兒石蔻散聯(lián)合雙歧桿菌三聯(lián)活菌散治療小兒抗生素相關(guān)性腹瀉的臨床觀察
[Abstract]Objective: Toexplore and analyze the clinical efectof Xiao'er Shikou Powder combined with Bifid Triple Viable Powder inthe treatmentof antibiotic-associated diarrheain children.Method: Atotal of112 children withantibiotic-associateddiarrheaadmited to Wenjiang Maternaland ChildHealth Care Hospital inChengdufrom February 2O2O to January 2O22 were selected and divided into the control group and the observation group according to the random number table method, with 56 cases in each group.Both groups were given conventional intervention. The control group was treated with Bifid Triple Viable Powder,and the observation group was treated with Xiao'er Shikou Powderon the basis of thecontrol group.The clinical eficacy,disappearance time of main symptoms and signs and the time for resuming normal eating of the two groups were compared.Thechanges of intestinal flora and immunefunctionindicators before and aftertreatmentinthetwo groups were compared.Meanwhile,theoccurrenceof adversereactions was observed.Result:The total clinical efective rate of the observation group was higher han that of thecontrol group,disappearance time of main symptoms and signs and the time for resuming normal eating were all earlier than those of the control group,the differences were statistically significant ( P <0.05).After the treatment, the intestinal floraand immune function indicatorsof the observation group were beter than those of the control group, thedifferenceswere statistically significant ( P <0.05).There wasno statistically significant difference in the incidence of adverse reactions between the two groups during the treatment period ( P >0.05). Conclusion: The combination of Xiao'er Shikou Powderand BifidTriple ViablePowder inthe treatmentofantibiotic-associated diarrhea inchildren canachievebeter clinical effects,promotethe improvementof clinical symptomsandsigns,shortenthedisappearance time of mainsymptoms,help regulate intestinal floraandthe immune functionof thebody,and doesnot increase adverse reactions during the treatment period.It is safe and reliable.
[Keywords]Xiao'er Shikou PowderBifid TripleViablePowderAntibiotic-associated diarrhea in children Intestinal flora
據(jù)調(diào)查資料顯示,小兒腹瀉發(fā)病率僅低于急性呼吸道感染,其中小兒抗生素相關(guān)腹瀉主要指的是患兒在應(yīng)用抗生素治療后對人體正常菌群造成破壞而出現(xiàn)的疾病類型,在疾病發(fā)生期間不僅可對腸黏膜及腸道上皮纖維毛造成不同程度的損傷,同時也進(jìn)一步的降低腸道細(xì)胞的雙糖酶活性,整體危害較為嚴(yán)重[]。(剩余5441字)
-
-
- 中國醫(yī)學(xué)創(chuàng)新
- 2025年21期
- 自體骨軟骨移植術(shù)聯(lián)合膠原蛋白軟...
- 宮腔灌注粒細(xì)胞集落刺激因子用于...
- 纖維支氣管鏡局部灌洗對重癥肺炎...
- 達(dá)格列凈聯(lián)合托拉塞米治療慢性心...
- 無創(chuàng)正壓通氣聯(lián)合前列地爾在CO...
- 人干擾素α1b聯(lián)合布地奈德霧化...
- 依托咪酯聯(lián)合丙泊酚全憑靜脈麻醉...
- 帕利哌酮緩釋片聯(lián)合氯氮平對難治...
- 子午流注針法擇時熱敏灸對脾虛痰...
- 改良森田療法聯(lián)合度洛西汀、帕羅...
- 蒼附益坤湯加減輔以來曲唑?qū)Χ嗄?..
- 改良桃紅四物湯聯(lián)合切開復(fù)位內(nèi)固...
- 清肺化痰飲輔助治療急性加重期支...
- 生脈注射液聯(lián)合重組人腦利鈉肽和...
- 小兒石蔻散聯(lián)合雙歧桿菌三聯(lián)活菌...
- 尼莫地平治療蛛網(wǎng)膜下腔出血后癥...
- 牽正散合活血通絡(luò)湯聯(lián)合依達(dá)拉奉...
- 地屈孕酮片對PCOS并不孕患者...
- 認(rèn)知行為干預(yù)聯(lián)合間歇性充氣壓力...
- 內(nèi)心意象療法聯(lián)合缺血分級護(hù)理對...
- 層級管理下責(zé)任制整體護(hù)理對輸尿...
- 前列腺剜除術(shù)后患者導(dǎo)尿管維護(hù)策...
- 干擾素聯(lián)合子宮頸聚焦超聲治療子...
- 自擬補(bǔ)腎疏肝方聯(lián)合針灸治療排卵...
- TDF+3TC+EFV方案與復(fù)...
- 術(shù)中冰凍病理對肺結(jié)節(jié)的診斷價值...
- 輸卵管積液對育齡婦女子宮內(nèi)膜形...
- TICL植人術(shù)與ICL植人術(shù)在...
- 復(fù)方丹參片聯(lián)合苯磺酸氨氯地平片...
- 下腔腓前韌帶錨釘縫線增強(qiáng)修復(fù)下...
- 坤泰膠囊聯(lián)合耳穴壓豆治療陰虛火...
- 針刺配合腹部推拿治療氣滯血瘀型...
- 參芪通脈湯治療糖尿病足的網(wǎng)絡(luò)藥...
- 腹腔鏡子宮肌瘤剔除術(shù)患者術(shù)后生...
- IL-6及血栓彈力圖預(yù)測慢性心...
- CTA與MRA診斷顱內(nèi)動脈瘤的...
- 肝臟衰弱指數(shù)聯(lián)合GBS對肝硬化...
- 原發(fā)性IgA腎病的治療研究進(jìn)展...
- 尿失禁相關(guān)性皮炎預(yù)防與治療的研...
- 鈉-葡萄糖共轉(zhuǎn)運(yùn)蛋白2抑制劑類...
- 穴位埋線治療非酒精性脂肪肝的研...